Personalis at NeoAG Summit 2018 Boston: NOV 15-16, 2018


Thursday, NOV 15 4:00 PM – 4:30 PM

Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.

ImmunoID NeXT Platform: Improving Neoantigen Prediction, TME Assessment, and ctDNA Detection for Vaccine Development

  • Innovative genomics methods for more comprehensive assessment of neoantigens
  • Improving neoantigen to MHC binding prediction and ranking
  • Assessing TME/TCR and tumor escape mechanisms that may impact vaccine response

Visit our exhibit at Neoantigen Summit 2018 in Boston!

Schedule a Meeting